Daiwa Securities Group Inc. Unity Biotechnology, Inc. Transaction History

Daiwa Securities Group Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$1.3 - $3.17 $149 - $364	-115 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$3.42 - $6.36 $526 - $979	-154 Reduced 57.25%	115 $1,000
Q1 2019 Apr 26, 2019	SELL	$7.65 - $16.66 $1,002 - $2,182	-131 Reduced 32.75%	269 $2,000
Q4 2018 Feb 05, 2019	BUY	$10.76 - $17.25 $4,304 - $6,900	400 New	400 $7,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.